(Q43190490)

15 November 2017

Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men. (English)

1 reference

15 November 2017

5

1 reference

15 November 2017

Iolanda Cirillo

1

1 reference

15 November 2017

Geert Mannens

2

1 reference

15 November 2017

Cor Janssen

3

1 reference

15 November 2017

Marc Vermeir

4

1 reference

15 November 2017

Daksha Desai-Krieger

6

1 reference

15 November 2017

Nicole Vaccaro

7

1 reference

15 November 2017

L Mark Kao

8

1 reference

15 November 2017

Damayanthi Devineni

9

1 reference

15 November 2017

Rebecca Redman

10

1 reference

15 November 2017

Kenneth Turner

11

1 reference

15 November 2017

language of work or name

English

0 references

publication date

21 July 2008

1 reference

Antimicrobial Agents and Chemotherapy

15 November 2017

1 reference

15 November 2017

52

1 reference

15 November 2017

3478-3483

1 reference

15 November 2017

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

15 November 2017

1 reference

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Activities of doripenem (S-4661) against drug-resistant clinical pathogens

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

In vitro antimicrobial activity of doripenem, a new carbapenem

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Comparative pharmacokinetics of the carbapenems: clinical implications

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Pharmacokinetics of meropenem in animals, healthy volunteers, and patients

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

The disposition and metabolic fate of 14C-meropenem in man.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565913

Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18644951

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00424-08

1 reference

15 November 2017

1 reference

15 November 2017

1 reference